Literature DB >> 3001144

Thrombomodulin is present in human plasma and urine.

H Ishii, P W Majerus.   

Abstract

Thrombomodulin is an endothelial cell membrane protein that is a cofactor required for the rapid activation of plasma protein C. We now report that plasma and urine of normal subjects contains a modified form of thrombomodulin that is soluble. The levels measured by radioimmunoassay were 292 +/- 60 ng thrombomodulin/ml plasma and 102 +/- 38 ng thrombomodulin/ml urine. Thrombomodulin was isolated from both plasma and urine by immunoaffinity chromatography using a polyclonal anti-human thrombomodulin IgG column. The apparent molecular weight of soluble thrombomodulin was estimated by immunoblot analysis using 125I-monoclonal anti-thrombomodulin IgG. When run without 2-mercaptoethanol, soluble thrombomodulin appeared as two polypeptides, Mr = 63,000 and 54,000, while samples run with 2-mercaptoethanol migrated mainly at Mr = 85,000. These results imply that the soluble form of thrombomodulin is smaller than the cellular form, presumably because of a lack of the membrane-binding domain. Soluble thrombomodulin is similar to cellular thrombomodulin in its intrinsic protein C-activating cofactor activity as measured by antibody neutralization. The apparent Km for protein C was the same for cellular and soluble thrombomodulin, while the soluble form requires a higher concentration of thrombin (three- to fivefold) for one-half maximal activity than the cellular form. Thrombomodulin functional activity cannot be directly measured in plasma because of some inhibitory substance(s). The physiological significance of circulating and urinary thrombomodulin is presently obscure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001144      PMCID: PMC424339          DOI: 10.1172/JCI112225

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

3.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.

Authors:  N L Esmon; W G Owen; C T Esmon
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

4.  Inactivation of human coagulation factor V by activated protein C.

Authors:  K Suzuki; J Stenflo; B Dahlbäck; B Teodorsson
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

Review 5.  A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis.

Authors:  H Wolinsky
Journal:  Circ Res       Date:  1980-09       Impact factor: 17.367

6.  Properties of the factor Xa binding site on human platelets.

Authors:  J P Miletich; C M Jackson; P W Majerus
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

7.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20

8.  Isolation and characterization of thrombomodulin from human placenta.

Authors:  H H Salem; I Maruyama; H Ishii; P W Majerus
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

9.  Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

Authors:  W Kisiel
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

10.  Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.

Authors:  I Maruyama; C E Bell; P W Majerus
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  37 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Plasma thrombomodulin in liver diseases.

Authors:  S Iwabuchi; Y Yoshida; A Kamogawa; N Moriyama; M Takatori; A Mizuguchi; T Uchikoshi; H Ishii; S Hiraishi; M Kazama
Journal:  Gastroenterol Jpn       Date:  1990-10

3.  Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.

Authors:  Ioannis Politikos; Haesook T Kim; Theodoros Karantanos; Julia Brown; Sean McDonough; Lequn Li; Corey Cutler; Joseph H Antin; Karen K Ballen; Jerome Ritz; Vassiliki A Boussiotis
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-21       Impact factor: 5.742

4.  Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation.

Authors:  Yesim Dargaud; Jean Yves Scoazec; Simone J H Wielders; Christine Trzeciak; Tilman M Hackeng; Claude Négrier; H Coenraad Hemker; Theo Lindhout; Elisabetta Castoldi
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

5.  Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.

Authors:  Yuko Suzuki; Hideto Sano; Liina Mochizuki; Naoki Honkura; Tetsumei Urano
Journal:  Blood Adv       Date:  2020-11-10

6.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

Review 7.  Hypercoagulable states and strokes.

Authors:  Nena Matijevic; Kenneth K Wu
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

8.  Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.

Authors:  T Iba; Y Yagi; A Kidokoro; M Fukunaga; T Fukunaga
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Does administration of eicosapentaenoic acid increase soluble thrombomodulin level in statin-treated patients with stable coronary artery disease?

Authors:  Shigemasa Tani; Rei Matsuo; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2018-08-24       Impact factor: 2.037

10.  Thrombomodulin in intensive care patients.

Authors:  J Boldt; T Wollbrück; S Sonneborn; A Welters; G Hempelmann
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.